No Data
Essence Pharmaceuticals: Report for the third quarter of 2024
Jinghua Pharmaceutical Plans to Divest Entire 18.6% Stake in Jinsili Pharmaceutical
Express News | jinghua pharmaceutical group: plans to sell the remaining equity of its equity company
jinghua pharmaceutical group (002349.SZ): The company and its subsidiaries are currently not engaging in CXO related business.
The Jinghua Pharmaceutical Group (002349.SZ) stated on the investor interaction platform on September 30 that the company and its subsidiaries are currently not engaged in CXO-related business.
Essence Pharmaceuticals: 2024 Semi-Annual Report Summary
Essence Pharmaceuticals: 2024 Semi-Annual Report
No Data
No Data